Mustang Bio Inc

Research Mustang Bio Inc (MBIO) on Bullrun: market cap USD 5.30M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMBIO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.30M
• Financial periodFY2025
• Net income-USD 1.92M

Valuation Snapshot

latest market cap is USD 5.30M.

About Mustang Bio Inc

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases;

Frequently asked questions

What is Mustang Bio Inc's market cap?

Mustang Bio Inc's market capitalization is USD 5.30M.

What does Mustang Bio Inc do?

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States.